incobotulinumtoxin A

DRUG4 trials

Sponsors

Icahn School of Medicine at Mount Sinai, Ulthera, Inc, Hannover Medical School, Zel Skin and Laser Specialists

Conditions

Androgenetic AlopeciaBorderline Personality DisorderDystoniaSkin Laxity

Phase 2

Incobotulinum Toxin A (Xeomin®) As A Treatment For Focal Task-Specific Dystonia Of The Musician's Hand

CompletedNCT02107261

Icahn School of Medicine at Mount SinaiDystonia

Start: 2014-03-31End: 2020-01-27Updated: 2023-05-11

Botulinum Toxin A for Emotional Stabilization in Borderline Personality Disorder (BPD)

CompletedNCT02728778

Hannover Medical SchoolBorderline Personality Disorder

Start: 2016-09-01End: 2019-10-31Updated: 2020-05-29

Use of Botulinum Toxin in the Treatment of Androgenic Alopecia

Active, not recruitingNCT05456087

Zel Skin and Laser SpecialistsAndrogenetic Alopecia

Start: 2022-08-12End: 2024-12-31Updated: 2024-03-27

Unknown Phase

Retrospective Evaluation of Combination Treatment With the Ulthera System

CompletedNCT02444169

Ulthera, IncSkin Laxity

Start: 2015-04-30End: 2015-07-31Updated: 2017-11-24

Related Papers

Clinical effects of glabellar botulinum toxin injections on borderline personality disorder: A randomized controlled trial

Journal of Psychopharmacology2022-02-0113 citations